Clinical experience of the Zydena drug in the therapy of erectile dysfunction

Abstract

The objective: to evaluate the efficacy and tolerability of the drug udenafil (ZYDENA), 100 mg tablets in the treatment of erectile dysfunction compared with the efficacy and tolerability of the reference drug (Sildenafil).Materials and methods. The clinical efficacy and safety of the ZYDENA drug in the treatment of erectile dysfunction in a clinical group of 35 patients with ED of mixed origin was studied. The control group included 30 patients who received Sildenafil therapy. Efficiency monitoring was carried out using the questionnaire on the scale of ICEF and dopplerography.Results. The excellent effect of therapy with udenafil was noted in 26 patients (74.3%), good – in 8 patients (22.8%), in one patient (2.9%) the effect was considered satisfactory. The final evaluation of the therapeutic efficacy showed «excellent» and «good» results in 97.1% of patients.Conclusions. The prescription of ZYDENA drug to patients with erectile dysfunction (100 mg) leads to a significant increase in integration parameters in 2 2.5 times, which is 1.15 1.25 times higher than in patients who used the drug Sildenafil. The clinical efficacy and safety of Zydena in the treatment of erectile dysfunction on a group of 35 patients with ED of mixed origin was studied. The control group consisted of 30 patients receiving therapy with Sildenafil. The effectiveness was monitored using a questionnaire on the ICEF scale and dopplerography. Purpose of the drug ZYDENA patients with erectile dysfunction (100 mg each) leads to a significant increase in integration parameters in 2 2.5 times, which is 1.15 1.25 times higher than in patients who used the drug Sildenafil. The clinical efficacy of ZYDENA is 97.1%. According to the duration of the action, ZYDENA is more effective than the reference preparation 2.38 times